Impact of psoriasis on quality of life in Iran

Indian Journal of Dermatology, Venereology and Leprology

Volumn 75, Issue 2, 2009, Pages 220-

  Aghaei, Shahin ^a   Moradi, Ahmad ^b   Ardekani, Gholamreza ^c  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Moradi Skin Laser Clinic   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dermatology; Psoriasis; Quality of Life

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PSORIASIS; PSORIASIS DISABILITY INDEX; PSORIASIS VULGARIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; ADOLESCENT; COMPARATIVE STUDY; MIDDLE AGED; MULTILINGUALISM; PSYCHOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; MULTILINGUALISM; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 63149178618     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.48689     Document Type: Article

References (29)

1. World Health Organisation. International Classification of impairments, Disabilities and Handicaps. Geneva: World Health Organization; 1980. p. 27-9
2. Calman KC. Quality of life in cancer patients-hypothesis. J Med Ethics 1984;10:124-7.
3. Price P, Harding KG. Defining quality of life. J Wound Care 1993;2:304-6.
4. De Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: A systematic literature review. J Invest Dermatol Symp Proc 2004;9:140-7.
5. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997;137:766-70.
6. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
7. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-7.
8. Fried RG, Friedman S, Paradis C, Hatach M, Lynfield Y, Duncanson C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101-5.
9. Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002;16:347-52.
10. Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-90.
11. Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, DeRie MA. The burden of psoriasis is not determined by disease severity only. J Invertig Dermatol Symp Proc 2004;9:131-5.
12. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or patient? Br J Cancer 1988;57:109-12.
13. Marks R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235-40.
14. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
15. Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004;4:8.
16. Nunnally JC. Psychometric theory. New York: McGraw-Hill; 1978.
17. Dave's Psoriasis Info. Available from: http://www.psorsite.com/docs/pasi. html. [Last accessed on November 26, 2004].
18. Finlay AY, Kelly SE. Psoriasis: An index of disability. Clin Exp Dermatol 1987;12:8-11.
19. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
20. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751-6.
21. Salek MS, Finlay AY. Cyclosporin improves quality of life in psoriasis: Does this matter? Br J Dermatol 1993;129:32.
22. Root S, Kent G, Al-Abadie MS. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994;189:234-7.
23. Kent G, Al-Abadie M. The psoriasis disability index: Further analyses. Clin Exp Dermatol 1993;18:414-6.
24. Parry EJ, Tillman DM, Long J. Audit of UVB phototherapy in the treatment of psoriasis. Br J Dermatol 1995;133:16.
25. Gledhill K, Keller-Jackson L, Cheesbrough M. Clinical psychology liaison in a dermatology clinic: A demonstration project. Presentation 6th International Congress on Dermatology and Psychology. Amsterdam, The Netherlands: 20-22 April 1995.
26. Picardi A, Abeni D, Melchi C, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: An issue to be recognized. Br J Dermatol 2000;143:983-91.
27. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143:51-4.
28. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients reffered to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997;19:29-35.
29. Stein KR, Pearce DJ, Feldman SR. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care. Semin Cutan Med Surg 2005;24:52-7.